
The fluorescent antibody test (FAT) is a method for diagnosing rabies in fresh or frozen brain tissues that is based on antigen detection and is recommended by the World Health Organization (WHO) and the World Organization for Animal Health (OIE). A reflected light fluorescence microscope is used to detect antigens.
Highlights
The global Fluorescent Antibody Test market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Fluorescent Antibody Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Fluorescent Antibody Test is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Fluorescent Antibody Test in Healthcare Providers is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Fluorescent Antibody Test include Quidel Corporation, BioTek Instruments, Thermo Fisher Scientific, Dewinter Optical, Leica Microsystems, PicoQuant GmbH, Carl Zeiss AG, Cole-Parmer Instrument Company and Esco Micro Pte, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Fluorescent Antibody Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluorescent Antibody Test.
The Fluorescent Antibody Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Fluorescent Antibody Test market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluorescent Antibody Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Quidel Corporation
BioTek Instruments
Thermo Fisher Scientific
Dewinter Optical
Leica Microsystems
PicoQuant GmbH
Carl Zeiss AG
Cole-Parmer Instrument Company
Esco Micro Pte
BR Technologies
Merck KGaA
OLYMPUS CORPORATION
labome
Segment by Type
Direct Test
Indirect Test
Segment by Application
Healthcare Providers
Pharmacies
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fluorescent Antibody Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fluorescent Antibody Test Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Direct Test
1.2.3 Indirect Test
1.3 Market by Application
1.3.1 Global Fluorescent Antibody Test Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Healthcare Providers
1.3.3 Pharmacies
1.3.4 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fluorescent Antibody Test Market Perspective (2018-2029)
2.2 Fluorescent Antibody Test Growth Trends by Region
2.2.1 Global Fluorescent Antibody Test Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Fluorescent Antibody Test Historic Market Size by Region (2018-2023)
2.2.3 Fluorescent Antibody Test Forecasted Market Size by Region (2024-2029)
2.3 Fluorescent Antibody Test Market Dynamics
2.3.1 Fluorescent Antibody Test Industry Trends
2.3.2 Fluorescent Antibody Test Market Drivers
2.3.3 Fluorescent Antibody Test Market Challenges
2.3.4 Fluorescent Antibody Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fluorescent Antibody Test Players by Revenue
3.1.1 Global Top Fluorescent Antibody Test Players by Revenue (2018-2023)
3.1.2 Global Fluorescent Antibody Test Revenue Market Share by Players (2018-2023)
3.2 Global Fluorescent Antibody Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fluorescent Antibody Test Revenue
3.4 Global Fluorescent Antibody Test Market Concentration Ratio
3.4.1 Global Fluorescent Antibody Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fluorescent Antibody Test Revenue in 2022
3.5 Fluorescent Antibody Test Key Players Head office and Area Served
3.6 Key Players Fluorescent Antibody Test Product Solution and Service
3.7 Date of Enter into Fluorescent Antibody Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fluorescent Antibody Test Breakdown Data by Type
4.1 Global Fluorescent Antibody Test Historic Market Size by Type (2018-2023)
4.2 Global Fluorescent Antibody Test Forecasted Market Size by Type (2024-2029)
5 Fluorescent Antibody Test Breakdown Data by Application
5.1 Global Fluorescent Antibody Test Historic Market Size by Application (2018-2023)
5.2 Global Fluorescent Antibody Test Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Fluorescent Antibody Test Market Size (2018-2029)
6.2 North America Fluorescent Antibody Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Fluorescent Antibody Test Market Size by Country (2018-2023)
6.4 North America Fluorescent Antibody Test Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fluorescent Antibody Test Market Size (2018-2029)
7.2 Europe Fluorescent Antibody Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Fluorescent Antibody Test Market Size by Country (2018-2023)
7.4 Europe Fluorescent Antibody Test Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fluorescent Antibody Test Market Size (2018-2029)
8.2 Asia-Pacific Fluorescent Antibody Test Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Fluorescent Antibody Test Market Size by Region (2018-2023)
8.4 Asia-Pacific Fluorescent Antibody Test Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fluorescent Antibody Test Market Size (2018-2029)
9.2 Latin America Fluorescent Antibody Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Fluorescent Antibody Test Market Size by Country (2018-2023)
9.4 Latin America Fluorescent Antibody Test Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fluorescent Antibody Test Market Size (2018-2029)
10.2 Middle East & Africa Fluorescent Antibody Test Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Fluorescent Antibody Test Market Size by Country (2018-2023)
10.4 Middle East & Africa Fluorescent Antibody Test Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Detail
11.1.2 Quidel Corporation Business Overview
11.1.3 Quidel Corporation Fluorescent Antibody Test Introduction
11.1.4 Quidel Corporation Revenue in Fluorescent Antibody Test Business (2018-2023)
11.1.5 Quidel Corporation Recent Development
11.2 BioTek Instruments
11.2.1 BioTek Instruments Company Detail
11.2.2 BioTek Instruments Business Overview
11.2.3 BioTek Instruments Fluorescent Antibody Test Introduction
11.2.4 BioTek Instruments Revenue in Fluorescent Antibody Test Business (2018-2023)
11.2.5 BioTek Instruments Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Fluorescent Antibody Test Introduction
11.3.4 Thermo Fisher Scientific Revenue in Fluorescent Antibody Test Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Dewinter Optical
11.4.1 Dewinter Optical Company Detail
11.4.2 Dewinter Optical Business Overview
11.4.3 Dewinter Optical Fluorescent Antibody Test Introduction
11.4.4 Dewinter Optical Revenue in Fluorescent Antibody Test Business (2018-2023)
11.4.5 Dewinter Optical Recent Development
11.5 Leica Microsystems
11.5.1 Leica Microsystems Company Detail
11.5.2 Leica Microsystems Business Overview
11.5.3 Leica Microsystems Fluorescent Antibody Test Introduction
11.5.4 Leica Microsystems Revenue in Fluorescent Antibody Test Business (2018-2023)
11.5.5 Leica Microsystems Recent Development
11.6 PicoQuant GmbH
11.6.1 PicoQuant GmbH Company Detail
11.6.2 PicoQuant GmbH Business Overview
11.6.3 PicoQuant GmbH Fluorescent Antibody Test Introduction
11.6.4 PicoQuant GmbH Revenue in Fluorescent Antibody Test Business (2018-2023)
11.6.5 PicoQuant GmbH Recent Development
11.7 Carl Zeiss AG
11.7.1 Carl Zeiss AG Company Detail
11.7.2 Carl Zeiss AG Business Overview
11.7.3 Carl Zeiss AG Fluorescent Antibody Test Introduction
11.7.4 Carl Zeiss AG Revenue in Fluorescent Antibody Test Business (2018-2023)
11.7.5 Carl Zeiss AG Recent Development
11.8 Cole-Parmer Instrument Company
11.8.1 Cole-Parmer Instrument Company Company Detail
11.8.2 Cole-Parmer Instrument Company Business Overview
11.8.3 Cole-Parmer Instrument Company Fluorescent Antibody Test Introduction
11.8.4 Cole-Parmer Instrument Company Revenue in Fluorescent Antibody Test Business (2018-2023)
11.8.5 Cole-Parmer Instrument Company Recent Development
11.9 Esco Micro Pte
11.9.1 Esco Micro Pte Company Detail
11.9.2 Esco Micro Pte Business Overview
11.9.3 Esco Micro Pte Fluorescent Antibody Test Introduction
11.9.4 Esco Micro Pte Revenue in Fluorescent Antibody Test Business (2018-2023)
11.9.5 Esco Micro Pte Recent Development
11.10 BR Technologies
11.10.1 BR Technologies Company Detail
11.10.2 BR Technologies Business Overview
11.10.3 BR Technologies Fluorescent Antibody Test Introduction
11.10.4 BR Technologies Revenue in Fluorescent Antibody Test Business (2018-2023)
11.10.5 BR Technologies Recent Development
11.11 Merck KGaA
11.11.1 Merck KGaA Company Detail
11.11.2 Merck KGaA Business Overview
11.11.3 Merck KGaA Fluorescent Antibody Test Introduction
11.11.4 Merck KGaA Revenue in Fluorescent Antibody Test Business (2018-2023)
11.11.5 Merck KGaA Recent Development
11.12 OLYMPUS CORPORATION
11.12.1 OLYMPUS CORPORATION Company Detail
11.12.2 OLYMPUS CORPORATION Business Overview
11.12.3 OLYMPUS CORPORATION Fluorescent Antibody Test Introduction
11.12.4 OLYMPUS CORPORATION Revenue in Fluorescent Antibody Test Business (2018-2023)
11.12.5 OLYMPUS CORPORATION Recent Development
11.13 labome
11.13.1 labome Company Detail
11.13.2 labome Business Overview
11.13.3 labome Fluorescent Antibody Test Introduction
11.13.4 labome Revenue in Fluorescent Antibody Test Business (2018-2023)
11.13.5 labome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Quidel Corporation
BioTek Instruments
Thermo Fisher Scientific
Dewinter Optical
Leica Microsystems
PicoQuant GmbH
Carl Zeiss AG
Cole-Parmer Instrument Company
Esco Micro Pte
BR Technologies
Merck KGaA
OLYMPUS CORPORATION
labome
Ìý
Ìý
*If Applicable.
